This guideline outlines the steps involved in conducting a TB interview for a contact investigation.
Favorite
2000
This videotape and CD-ROM provide guidance to respiratory protection administrators in the development of programs to prevent TB through respirator use.
Favorite
Infection Control and Occupational Health Workers
2000
This book is for health care workers considering embarking on TB control in prisons and covers structural, administrative, and medical issues. It is designed primarily for use in settings where there is a high incidence of TB and limited resources.
Favorite
Correctional Facility Staff
2000
This pamphlet, available online only, explains the causes and symptoms of TB and differentiates between active TB disease and latent TB infection. It was adapted by the Division of Tuberculosis Control, Virginia Department of Health, from materials developed in 1993 by the New York State Department of Health.
Favorite
2000
This fact sheet, available online or via fax only, discusses the tuberculin skin test and when to suspect TB disease. Specifically, it discusses administering the tuberculin skin test, interpreting the results, false-positive and false-negative results, two-step testing, anergy, and interpreting reactions in persons vaccinated with BCG.
Favorite
Infection Control and Occupational Health Workers
2000
This book provides government and nongovernment entities involved in TB elimination with background on the pathology of TB, its history, and the public and private response to TB in the United States.
Favorite
Community Leaders
2000
This manual provides a structured plan for the training, development and evaluation of healthcare workers involved in contact investigation. It focuses on interview techniques and communication skills and provides data collection instruments for the provision of objective feedback to the interviewer.
Favorite
Managers and Supervisors
2000
This study examined the clinic records of TB programs to determine whether these programs used recommended practices to manage HIV-positive persons exposed to TB. The study suggests that TB programs need to review their contact investigation policies, procedures, and outcomes to reduce missed opportunities for preventing active TB among HIV-positive close contacts.
Favorite
2000
This report describes an outbreak of drug-susceptible TB that occurred in a South Carolina state correctional facility housing HIV-infected inmates and illustrates the need for increased vigilance for TB in settings in which HIV-infected persons congregate.
Favorite
2000
This report describes findings from two cases in which TB was misdiagnosed due to laboratory cross-contamination and summarizes the results of the ensuing investigation, which demonstrated the value of DNA fingerprinting to identify occurrences of cross-contamination among patient specimens.
Favorite
2000
This guideline presents updated data about drug interactions between protease inhibitors and non-nucleoside reverse transcriptase inhibitors for treatment of HIV infection together with rifamycins for treatment of TB.
Favorite
2000
This notice explains that on September 30, 1999, the Food and Drug Administration approved a reformulated amplified Mycobacterium Tuberculosis Direct (MTD) test for detection of Mycobacterium tuberculosis in acid-fast Bacille (AFB) smear-positive and smear-negative respiratory specimens from patients suspected of having TB.
Favorite
Lab Personnel
2000
This report discusses the economic, psychological, and social impacts of TB and the strategies that households use to cope with them.
Favorite
International Agencies
2000
This report discusses the relationship between TB and sustainable development, and advocates for increased dialogue and action among TB partners.
Favorite
International Agencies
2000
This report describes World TB Day events and activities that took place on March 24, 2000 to raise public awareness about the extent of the TB epidemic in various countries and territories around the world.
Favorite
Community Leaders
International Agencies
2000
This booklet explains the relationship between MDR-TB, DOTS, and DOTS-Plus and how projects can become a DOTS-Plus pilot project that can benefit from concessionary prices negotiated for second-line anti-TB drugs by the Working Group.
Favorite
Managers and Supervisors
2000
This brochure indicates that although TB affects people worldwide, it can be prevented, treated, and cured. The brochure also lists the symptoms of TB and those individuals who are at risk for TB.
Favorite
2000
This guideline is intended to provide a framework and understanding of the diagnostic approaches to TB infection/disease and to present a classification scheme that facilitates management of all persons who have had diagnostic tests.
Favorite
2000
This report presents the findings of a short-term study to examine the risk of TB among health care workers. It discusses the possible effects of federal guidelines, responses to resurgent TB, and proposed strategies for eliminating TB in the United States and worldwide.
Favorite
Health Educators/Communicators
Infection Control and Occupational Health Workers
2001
This pamphlet discusses the use of the drug isoniazid (INH) to treat latent TB infection. It provides information on the length of treatment and side effects.
Favorite
2001
